What Not to Do on Wegovy — and Why It Matters

Eating patterns that fight against how semaglutide works

Clinical trial participants on semaglutide followed structured dietary advice alongside injections, and that context matters. The STEP 1 trial, published in the New England Journal of Medicine, combined semaglutide 2.4mg with a reduced-calorie diet and increased physical activity, the licence reflects exactly that combination. Wegovy does not replace the dietary change; it works alongside it.

The most reported mistake is continuing to eat large, high-fat meals on the assumption that the medicine will compensate. It won't. Semaglutide slows gastric emptying, so food stays in the stomach longer. Rich or greasy meals sit longer too, and nausea becomes the predictable result. Small meals, eaten slowly, with adequate protein and fibre, tend to be far better tolerated. This is not about restriction for its own sake; it is basic physiology.

Alcohol deserves its own mention. Beyond the calorie content, heavy drinking dehydrates you, and dehydration on top of GI side effects can become a clinical problem. If you're also managing blood sugar with other medicines, alcohol introduces hypoglycaemia risk. The NHS medicines page for semaglutide covers this plainly. Our page on what to do when on Wegovy has practical guidance on diet and hydration alongside treatment.

Dose management errors (what not to do if a dose is late or missed

A question our prescribers hear most weeks is: "I missed my injection) do I take two next week to catch up?" The answer is no, and the reasoning is straightforward. Doubling up does not restore the steady pharmacokinetic profile the medicine relies on; it substantially increases your side-effect burden without a proportional benefit. If your missed dose falls within four days of its scheduled day, take it as soon as you remember. Beyond that, skip to the next scheduled dose. The exact rules are in your Patient Information Leaflet, which is authoritative on this, not general advice from a blog or a friend on the same treatment.

Stopping Wegovy abruptly without clinical discussion is another common mistake. Weight regain following discontinuation has been observed in trial data. If you're struggling with side effects or questioning whether to continue, the right step is a conversation with your prescriber. Our prescribers are available seven days a week for exactly this kind of aftercare question. You can also read through our broader overview of how Wegovy works and what to expect before raising concerns.

Titrating yourself (deciding independently to stay on a lower dose longer or jump to the next level early) also sits outside what's clinically appropriate. The dose-escalation schedule exists because the trial data showed it reduces side effects at initiation. Your prescriber reviews each step.

Medicine interactions people often overlook

The interaction picture for Wegovy is not exhaustive, but some categories carry real clinical weight. Oral contraceptives are the most frequently underestimated. Semaglutide slows gastric emptying, which in principle can alter how quickly an oral contraceptive is absorbed. UK guidance on medicines to avoid or monitor on Wegovy covers this in detail. The NHS England guidance on weight-management injections specifically flags this interaction; a non-oral form of contraception may be advisable, and your prescriber will discuss this at consultation.

If you take any medicines for type 2 diabetes alongside Wegovy, notably insulin or sulphonylureas, your prescriber needs to know. Semaglutide lowers blood sugar in its own right, and combining it with other glucose-lowering agents without clinical oversight increases hypoglycaemia risk. Disclose everything, including over-the-counter medicines, supplements, and herbal products. The full interaction picture for semaglutide is covered on our semaglutide interactions page, and for related concerns you may want to read what you cannot take with semaglutide.

One more category: if any surgical or dental procedure is planned, your surgical team and anaesthetist must know you are taking a GLP-1 medicine. Slowed gastric emptying has implications for anaesthesia and aspiration risk. This applies even for a routine procedure under sedation. Mention it proactively; do not assume it is in your records.

When to get medical help, the signs not to ignore

Most people on Wegovy experience some GI side effects, particularly in the first few weeks or after a dose increase. Nausea, loose stools, bloating and reduced appetite are common and, for most people, settle. What is not normal: severe, persistent abdominal pain that radiates to the back, which may indicate pancreatitis. Following its January 2026 Drug Safety Update, the MHRA asks patients to report suspected side effects via the Yellow Card scheme, and to seek urgent medical attention for this symptom pattern. Do not wait it out.

Severe vomiting or diarrhoea lasting more than a day or two carries dehydration risk. Signs of an allergic reaction (swelling of the face, lips or throat, difficulty breathing) require emergency care. Low mood or thoughts of self-harm, while uncommon, should prompt immediate contact with a clinician. If you're uncertain whether something warrants a call, err on the side of calling. Our support team is available seven days a week and will direct you to the right care.

Wegovy is a clinically effective medicine for the right person, used correctly. The guidance above reflects what clinical teams and regulators have learned from large-scale trial data and real-world use. If you are considering treatment and want to understand whether it suits your circumstances, a free consultation with our prescribers is the place to start. You can also explore the broader range of weight-loss treatment options we support.